Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.

IF 3.4 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Yingkun Zhao, Wujiao Wang, Yi Cai, Bo Liu, Peifen Chang, Tianli Li, Peng Yang
{"title":"Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.","authors":"Yingkun Zhao, Wujiao Wang, Yi Cai, Bo Liu, Peifen Chang, Tianli Li, Peng Yang","doi":"10.1186/s40001-025-03031-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To systematically evaluate the effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention (PCI).</p><p><strong>Methods: </strong>From the time the database was constructed to May 28, 2025, Eight databases and two registry systems, including Web of Science, Cochrane Library, PubMed, Embase, China National Knowledge Infrastructure (CNKI), Wanfang database, China Science and Technology Journal Database (VIP), Chinese Biomedical Literature database (CBM), Clinical Trials, and the China Clinical Trials Registry were searched-clinical randomized controlled trials (RCTs) of Baduanjin in treating patients after PCI were retrieved. The primary outcomes were the 6-min walk test (6MWT) and left ventricular ejection fraction (LVEF). Secondary outcomes were Major adverse cardiovascular event (MACE), Seattle Angina Questionnaire (SAQ), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Anaerobic threshold (AT), Metabolic equivalent of task (METs), and Maximal oxygen consumption (VO<sub>2</sub> max). The quality of the included studies was assessed using the Cochrane Risk of Bias assessment tool, version 2.0 (RoB 2). Meta-analysis was performed using RevMan 5.4 software. Sensitivity analysis and subgroup analysis were performed using Stata software. In addition, Publication bias was evaluated using funnel plots and Egger's test.</p><p><strong>Results: </strong>A total of 56 RCTs involving 5152 patients were included in the study. Compared with the control group, the Baduanjin group showed superior improvement in LVEF (MD = 5.55%, 95% CI [4.28%, 6.82%], P < 0.01, I<sup>2</sup> = 94%), 6MWT (MD = 57.68m, 95% CI [40.20m, 75.17m], P < 0.01, I<sup>2</sup> = 100%), MACE (RR = 0.33, 95% CI [0.26, 0.42], P < 0.01, I<sup>2</sup> = 0%), SAQ-PL (MD = 7.49 points, 95% CI [4.78 points, 10.20 points], P < 0.01, I<sup>2</sup> = 91%), SAQ-AS (MD = 12.88 points, 95% CI [10.76 points, 15.00 points], P < 0.01, I<sup>2</sup> = 77%), SAQ-DS (MD = 11.30 points, 95% CI [5.14 points, 17.45 points], P < 0.01, I<sup>2</sup> = 98%), SAQ-AF (MD = 10.90 points, 95% CI [6.05 points, 15.75 points], P < 0.01, I<sup>2</sup> = 98%), SAQ-TS (MD = 8.04 points, 95% CI [2.30 points, 13.78 points], P < 0.01, I<sup>2</sup> = 98%), SAS (MD = - 7.01 points, 95% CI [- 8.05 points, - 5.96 points], P < 0.01, I<sup>2</sup> = 58%), SDS (MD = - 6.67 points, 95% CI [- 8.34 points, - 5.00 points], P < 0.01, I<sup>2</sup> = 89%), VO<sub>2</sub>peak (MD = 1.81 mL/kg/min, 95% CI [0.82 mL/kg/min, 2.80 mL/kg/min], P < 0.01, I<sup>2</sup> = 96%), AT (MD = 1.18 mL/kg/min, 95% CI [0.66 mL/kg/min, 1.69 mL/kg/min], P < 0.01, I<sup>2</sup> = 96%), and METs (MD = 0.61 METs, 95% CI [0.32 METs, 0.90 METs], P < 0.01, I<sup>2</sup> = 83%) when compared to control groups. Subgroup analysis showed that patients with chronic coronary syndromes (CCS) were more suitable as a target population. Improvement in LVEF was better with intervention duration of 1-3 months, whereas improvement in 6MWT was better with intervention longer than 3 months, and it is not recommended to combine Baduanjin with aerobic exercise.</p><p><strong>Conclusions: </strong>Baduanjin can improve cardiopulmonary function, alleviate clinical symptoms, improve quality of life, adjust mental state, and reduce the incidence of MACE in patients after PCI.</p><p><strong>Systematic review registration: </strong>CRD42024626379.</p>","PeriodicalId":11949,"journal":{"name":"European Journal of Medical Research","volume":"30 1","pages":"889"},"PeriodicalIF":3.4000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482649/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40001-025-03031-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To systematically evaluate the effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention (PCI).

Methods: From the time the database was constructed to May 28, 2025, Eight databases and two registry systems, including Web of Science, Cochrane Library, PubMed, Embase, China National Knowledge Infrastructure (CNKI), Wanfang database, China Science and Technology Journal Database (VIP), Chinese Biomedical Literature database (CBM), Clinical Trials, and the China Clinical Trials Registry were searched-clinical randomized controlled trials (RCTs) of Baduanjin in treating patients after PCI were retrieved. The primary outcomes were the 6-min walk test (6MWT) and left ventricular ejection fraction (LVEF). Secondary outcomes were Major adverse cardiovascular event (MACE), Seattle Angina Questionnaire (SAQ), Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Anaerobic threshold (AT), Metabolic equivalent of task (METs), and Maximal oxygen consumption (VO2 max). The quality of the included studies was assessed using the Cochrane Risk of Bias assessment tool, version 2.0 (RoB 2). Meta-analysis was performed using RevMan 5.4 software. Sensitivity analysis and subgroup analysis were performed using Stata software. In addition, Publication bias was evaluated using funnel plots and Egger's test.

Results: A total of 56 RCTs involving 5152 patients were included in the study. Compared with the control group, the Baduanjin group showed superior improvement in LVEF (MD = 5.55%, 95% CI [4.28%, 6.82%], P < 0.01, I2 = 94%), 6MWT (MD = 57.68m, 95% CI [40.20m, 75.17m], P < 0.01, I2 = 100%), MACE (RR = 0.33, 95% CI [0.26, 0.42], P < 0.01, I2 = 0%), SAQ-PL (MD = 7.49 points, 95% CI [4.78 points, 10.20 points], P < 0.01, I2 = 91%), SAQ-AS (MD = 12.88 points, 95% CI [10.76 points, 15.00 points], P < 0.01, I2 = 77%), SAQ-DS (MD = 11.30 points, 95% CI [5.14 points, 17.45 points], P < 0.01, I2 = 98%), SAQ-AF (MD = 10.90 points, 95% CI [6.05 points, 15.75 points], P < 0.01, I2 = 98%), SAQ-TS (MD = 8.04 points, 95% CI [2.30 points, 13.78 points], P < 0.01, I2 = 98%), SAS (MD = - 7.01 points, 95% CI [- 8.05 points, - 5.96 points], P < 0.01, I2 = 58%), SDS (MD = - 6.67 points, 95% CI [- 8.34 points, - 5.00 points], P < 0.01, I2 = 89%), VO2peak (MD = 1.81 mL/kg/min, 95% CI [0.82 mL/kg/min, 2.80 mL/kg/min], P < 0.01, I2 = 96%), AT (MD = 1.18 mL/kg/min, 95% CI [0.66 mL/kg/min, 1.69 mL/kg/min], P < 0.01, I2 = 96%), and METs (MD = 0.61 METs, 95% CI [0.32 METs, 0.90 METs], P < 0.01, I2 = 83%) when compared to control groups. Subgroup analysis showed that patients with chronic coronary syndromes (CCS) were more suitable as a target population. Improvement in LVEF was better with intervention duration of 1-3 months, whereas improvement in 6MWT was better with intervention longer than 3 months, and it is not recommended to combine Baduanjin with aerobic exercise.

Conclusions: Baduanjin can improve cardiopulmonary function, alleviate clinical symptoms, improve quality of life, adjust mental state, and reduce the incidence of MACE in patients after PCI.

Systematic review registration: CRD42024626379.

八段锦运动对经皮冠状动脉介入治疗后心脏康复的影响:随机对照试验的系统回顾和meta分析。
目的:系统评价八段锦运动对经皮冠状动脉介入治疗(PCI)术后心脏康复的影响。方法:从数据库建成到2025年5月28日,共建设了Web of Science、Cochrane Library、PubMed、Embase、中国知网(CNKI)、万方数据库、中国科技期刊库(VIP)、中国生物医学文献库(CBM)、临床试验、和中国临床试验注册中心检索八段金治疗PCI术后患者的临床随机对照试验(rct)。主要结果为6分钟步行测试(6MWT)和左心室射血分数(LVEF)。次要结局为主要不良心血管事件(MACE)、西雅图心绞痛问卷(SAQ)、焦虑自评量表(SAS)、抑郁自评量表(SDS)、无氧阈值(AT)、任务代谢当量(METs)和最大耗氧量(VO2 max)。采用Cochrane 2.0版偏倚风险评估工具(RoB 2)对纳入研究的质量进行评估。采用RevMan 5.4软件进行meta分析。采用Stata软件进行敏感性分析和亚组分析。此外,采用漏斗图和Egger检验评估发表偏倚。结果:共纳入56项rct, 5152例患者。与对照组相比,Baduanjin集团卓越的改善LVEF (MD = 5.55%, 95%可信区间(4.28%、6.82%),P 2 = 94%), 6 mwt (MD = 57.68 m, 95%可信区间(40.20,40.20),页2 = 100%),梅斯(RR = 0.33, 95%可信区间[0.26,0.42],P 2 = 0%), SAQ-PL (MD = 7.49点,95%可信区间(4.78分,10.20分),P 2 = 91%), SAQ-AS (MD = 12.88点,95%可信区间(10.76分,15.00分),P 2 = 77%), SAQ-DS (MD = 11.30点,95%可信区间(5.14分,17.45分),P 2 = 98%), SAQ-AF (MD = 10.90点,95%可信区间(6.05分,15.75分),P 2 = 98%), SAQ-TS (MD = 8.04点,95%可信区间(2.30分,13.78分),P 2 = 98%), SAS (MD = - 7.01分,95%可信区间(- 8.05分,5.96分),P 2 = 58%), SDS (MD = - 6.67分,95%可信区间(- 8.34分,5.00分),P 2 = 89%), VO2peak (MD = 1.81 mL / kg /分钟,95%可信区间(0.82毫升/公斤/分钟,2.80毫升/公斤/分钟),P 2 = 96%),在(MD = 1.18 mL / kg /分钟,95%可信区间(0.66毫升/公斤/分钟,1.69毫升/公斤/分钟),P 2 = 96%),和大都会(MD大都会= 0.61,95% CI 0.32大都会,0.90大都会,P 2 = 83%)。亚组分析显示,慢性冠状动脉综合征(CCS)患者更适合作为目标人群。干预时间1-3个月LVEF改善效果较好,干预时间超过3个月6MWT改善效果较好,不建议八段锦与有氧运动联合使用。结论:八段锦可改善PCI术后患者心肺功能,缓解临床症状,改善生活质量,调节精神状态,降低MACE发生率。系统评价注册:CRD42024626379。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Medical Research
European Journal of Medical Research 医学-医学:研究与实验
CiteScore
3.20
自引率
0.00%
发文量
247
审稿时长
>12 weeks
期刊介绍: European Journal of Medical Research publishes translational and clinical research of international interest across all medical disciplines, enabling clinicians and other researchers to learn about developments and innovations within these disciplines and across the boundaries between disciplines. The journal publishes high quality research and reviews and aims to ensure that the results of all well-conducted research are published, regardless of their outcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信